Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD).
Publication
, Conference
Ciulla, TA; Jaffe, GJ; Patel, S
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
September 1, 2016
Duke Scholars
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
September 1, 2016
Volume
57
Issue
12
Location
Seattle, WA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ciulla, T. A., Jaffe, G. J., & Patel, S. (2016). Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD). In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 57). Seattle, WA: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Ciulla, Thomas A., Glenn J. Jaffe, and Samir Patel. “Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD).” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 57. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2016.
Ciulla TA, Jaffe GJ, Patel S. Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD). In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2016.
Ciulla, Thomas A., et al. “Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD).” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 57, no. 12, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2016.
Ciulla TA, Jaffe GJ, Patel S. Assessment of Retinal Pigment Epithelium (RPE) Atrophy in a Phase 2b Study of a Platelet Derived Growth Factor inhibitor (Fovista (R)), in combination with a Vascular Endothelial Growth Factor inhibitor (Ranibizumab) for Neovascular Age-Related Macular Degeneration (NAMD). INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2016.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
September 1, 2016
Volume
57
Issue
12
Location
Seattle, WA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences